According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.
Three gurus are invested in Meridian Bioscience Inc. (VIVO, Financial).
The integrated life sciences company has a market cap of $630.39 million. Its revenue has grown 4.60% annually over the past 10 years.
The stock is trading with a price-earnings ratio of 29.24. The current price of $14.9 is 9.42% below its 52-week high and 12.62% above its 52-week low. Over the past 10 years, it has returned a loss of 46%.
The company’s largest shareholder among the gurus is Jim Simons (Trades, Portfolio) with 5.27% of outstanding shares, followed by Mario Gabelli (Trades, Portfolio) with 0.41%, Joel Greenblatt (Trades, Portfolio) with 0.38% and Barrow, Hanley, Mewhinney & Strauss with 0.35%.
Three gurus have positions in Quest Diagnostics Inc. (DGX, Financial).
The company, which provides diagnostic testing, information and services to enable patients and physicians to make decisions about health care, has a market cap of $13.77 billion. Its revenue has grown 4.70% annually for the past decade.
The stock is trading with a price-book ratio of 2.74. The current price of $101.36 is 10.27% below its 52-week high and 12.50% above its 52-week low. Over the last 10 years, it has returned a gain of 106%.
Simons is the company's largest shareholder among the gurus with 0.64% of outstanding shares, followed by Greenblatt with 0.19%, John Rogers (Trades, Portfolio) with 0.18% and Chris Davis (Trades, Portfolio) with 0.1%.
Five gurus hold Laboratory Corp. of America Holdings (LH, Financial).
The company, which provides comprehensive clinical laboratory and end-to-end drug development services, has a market cap of $17.59 billion. Its revenue has grown 11.30% over the past decade.
The stock is trading with a price-earnings ratio of 2.55. The current price of $172.48 is 5.08% below its 52-week high and 26.26% above its 52-week low. Over the past decade, it has returned a gain of 129%.
The largest guru shareholder of the company is Larry Robbins (Trades, Portfolio) with 2.62% of outstanding shares, followed by Rogers with 1.2% and Simons with 0.74%.
Three gurus have positions in Medpace Holdings Inc. (MEDP, Financial).
The clinical contract research company has a market cap of $1.33 billion.
The stock is trading with a price-book ratio of 2.60. The current price of $37.35 is 5.78% below its 52-week high and 71.56% above its 52-week low. Over the past 10 years, it has returned a gain of 34%.
Ken Fisher (Trades, Portfolio) is the company's largest guru shareholder with 0.52% of outstanding shares, followed by Simons with 0.51%, Greenblatt with 0.03% and Paul Tudor Jones (Trades, Portfolio) with 0.02%.
Five gurus hold Thermo Fisher Scientific Inc. (TMO, Financial).
The company, which provides analytical instruments, laboratory equipment, reagents and chemicals, has a market cap of $86.03 billion. Its revenue has grown 9.40% over a 10-year period.
The stock is trading with a price-book ratio of 1.53. The current price of $213.84 is 5.56% below its 52-week high and 29.78% above its 52-week low. Over the past 10 years, it has returned a gain of 274%.
The company’s largest shareholder among the gurus is PRIMECAP Management (Trades, Portfolio) with 1.28% of outstanding shares, followed by the Vanguard Health Care Fund (Trades, Portfolio) with 0.84% and Robbins with 0.83%.
Disclosure: I do not own any stocks mentioned in this article.
